CAS:6020-87-7 Crea...

CAS:6020-87-7  Creatine monohydrate

CAS:6020-87-7 Creatine monohydrate

Min.Order / FOB Price:Get Latest Price

1 Kilogram

Negotiable

  • Min.Order :1 Kilogram
  • Purity: 99.5%
  • Payment Terms : T/T,Other

Keywords

Creatine monohydrate Creatine monohydrate N-Amidinosarcosine

Quick Details

  • Appearance:White powder
  • Application:White Crystalline Odorless
  • PackAge:according to customers' requirements
  • ProductionCapacity:100|Kilogram|Month
  • Storage:store in cool and dry
  • Transportation:by sea or by air

Superiority:

Specification of  Creatine monohydrate

Item

Specifications

Results

Appearance

White Crystalline Odorless

White Crystalline Odorless

Assay

99.90%

99.93%

Loss on Drying

≤11.50%

11.25%

Creatinine

50ppm

Conforms

Dicyanamide

≤20ppm

Conforms

Cyanide

≤1ppm

Conforms

Heavy Metals

≤10 ppm

Conforms

As

≤1ppm

Conforms

Lead

≤3 ppm

Conforms

Mercury

≤0.1 ppm

Conforms

Cadmium

≤1 ppm

Conforms

Residue on Ignition

0.1%

0.02%

Sulphate

0.03%

Conforms

Total Plate Count

≤10cfu/gm

Conforms

Coliform

Negative

Conforms

E.Coli & Salmonella

Negative

Conforms

Yeast & Mould

Negative

Conforms

Solution

Clear and Colorless

Conforms

Impurity

≤1%

0.11%

Conclusion

The results conforms with Enterprise standards

 

 

More About  Creatine monohydrate

 

CAS: 6020-87-7

Synonyms: N-GUANYL-N-METHYLGLYCINE;N-GUANYL-N-METHYLGLYCINE, MONOHYDRATE;N-METHYL-N-GUANYLGLYCINE MONOHYDRATE;N-AMIDINOSARCOSINE;N-AMIDINOSARCOSINE HYDRATE;N-AMIDINOSARCOSINE MONOHYDRATE;Glycine, N-(aminoiminomethyl)-N-methyl-, monohydrate;CREATINE HYDRATE

MF: C4H11N3O3

Details:

Kono Chem Co.,Ltd is a leading producer of standardized herbal extracts, natural active ingredients and APIs for pharmaceutical, health food and cosmetic industries. 

The botanical raw materials are subject to strict selection and inspection, and extracts are manufactured according to methods developed by Pioneer. They include inspections to guarantee a high quality standard from both analytico-chemical and therapeutic points of view, and take into consideration the state of art in different fields: research and development, analyses, processes and machinery, therapeutic applications on a scientific basis. 

With our phytopharmaceutical background and knowledge through experience, PIONEER can also provide a wide range of analytical services and reference substances to our clients. In addition, We also manufacture pharmaceutical raw materials of nucleotide species, mainly including as below: SAM-e Tosylate Disulfate; SAM-e 1,4-Butanedisulfonate; Polycytidylic Acid; Polyinosinic Acid; Adenosine Triphosphate Disodium; and Cytidine Triphosphate Disodium; these items are our strongest advantage in China. Meanwhile, we can do custom made pharmaceutical ingredients depending on our professional experts in the pharmaceutical and chemistry industry. 

Recently, Kono Chem has been working hard on the research and development of new cardiovascular and anesthesia drugs, we have got good achievements; moreover, we also offer natural anticancer drugs and other pharmaceutical intermediates. As a GMP standardized manufacturer, our products can meet or even exceed the standards of CP2010, USP32, BP2005 and EP4. Presently, 80% and above of our products have been well-recognized in dozens of countries and regions, such as USA, EU, South America and Southeast Asia. There are experienced technicians working for our institutes now, all of them are skilled. Pioneer is looking forward to cooperating with friends all over the world for getting collaborative development; we are willing to work with you to develop new drugs and expand new business, let's work together for bright future.

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View